Does VALSARTAN Cause Ejection fraction decreased? 148 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Ejection fraction decreased have been filed in association with VALSARTAN (valsartan). This represents 0.7% of all adverse event reports for VALSARTAN.
148
Reports of Ejection fraction decreased with VALSARTAN
0.7%
of all VALSARTAN reports
5
Deaths
57
Hospitalizations
How Dangerous Is Ejection fraction decreased From VALSARTAN?
Of the 148 reports, 5 (3.4%) resulted in death, 57 (38.5%) required hospitalization, and 3 (2.0%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALSARTAN. However, 148 reports have been filed with the FAERS database.
What Other Side Effects Does VALSARTAN Cause?
Drug ineffective (1,845)
Blood pressure increased (1,682)
Dizziness (1,527)
Headache (1,361)
Hypertension (1,341)
Acute kidney injury (1,301)
Dyspnoea (1,239)
Fatigue (1,156)
Malaise (1,139)
Hypotension (1,032)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which VALSARTAN Alternatives Have Lower Ejection fraction decreased Risk?
VALSARTAN vs VALTREX
VALSARTAN vs VAMOROLONE
VALSARTAN vs VANCOMYCIN
VALSARTAN vs VANDETANIB
VALSARTAN vs VARDENAFIL